The use of rating scales in the quest for effective treatment of inflammatory skin disease is standard for clinical trials, but the associated processes can be confusing and available resources vary widely from indication to indication.

• Is there a scale training course available?
• How do I obtain authorization for use?
• What is the difference between IGA and PGA?
• Which version of the assessment is being used in my study?

These issues can create a crisis for study teams and the Clinical Trial Project Manager. Thalocan specializes in the navigation of these issues, ensuring that you have what you need, on time and under budget.